[Media Releases] LegoChem announces patent for a manufacturing method of methane…(kosdaq disclosure, 14 July 2014)

Title:  LegoChem announces patent for a manufacturing method of methane…

Publication: Disclosed on Kosdaq

Date: 14 July 2014

URL: link to website (contents in Korean)

Summary

LegoChem Biosciences received a patent on July 14, for a manufacturing method of methane for PAR-2 inhibitor. (Patent number of 10-2012-0155892)

About LegoChem Biosciences

LegoChem Biosciences, Inc. (LCB) is a research-based biotechnology company dedicated to discovering, developing, and commercializing innovative medicines by leveraging our chemistry expertise to make conventional biologics targeted and more potent for the benefit of patients with diseases of high unmet medical needs. We are advancing sustainable pipelines in therapeutic areas in antibiotics, anti-coagulants, oncology, antibody-drug conjugate (ADC), and protein-drug conjugate (PDC).